Clinical Trial

International Genetic Obesity Registry

Study acronym: iGO Registry
Recruiting
View on ClinicalTrials.gov →
Summary
Genetic obesity results from changes in specific genes that affect appetite regulation, metabolism, and fat storage. Its severity and associated health issues vary depending on the genetic cause. In some cases, hormonal imbalances, developmental delays, or other complications may also occur. Identifying the genetic cause is essential for personalized treatment and understanding potential symptoms. As genetic obesity is rare, specialists often encounter few patients with diverse genetic backgrounds and clinical features. Therefore, collecting global data is crucial to improve our understanding of the condition's progression, complications, and treatment responses for each genetic subtype. To support this, the International Genetic Obesity Registry (iGO Registry) has been established to gather detailed patient information on genetic obesity. This registry will help advance research and improve clinical care for affected individuals. It will collect data from routine outpatient visits, focusing on relevant diagnostic and treatment information on an international level.
Trial Details
NCT Number NCT07296900
Lead Sponsor University of Ulm
Conditions Genetic Obesity
Enrollment 5,000 participants
Start Date 2025-11-17
Primary Completion 2075-11 (estimated)
Study Completion 2075-11 (estimated)
Updated on ClinicalTrials.gov 2025-12-22